Point72 Asset Management
MNPR icon

Point72 Asset Management’s Monopar Therapeutics MNPR Stock Holding History

Point72 Asset Management’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$3.72M Sell
104,019
-64,141
-38% -$2.29M 0.01% 743
2025
Q1 		$6.12M Buy
168,160
+268
+0.2% +$9.76K 0.01% 619
2024
Q4 		$3.69M Buy
+167,892
New +$3.69M 0.01% 715